Work

Early Signs and Symptoms of Relapse among Adults with Opioid Use Disorder: A Mixed-Methods Study

Year: 2023
Type: article
Study design: Observational Study
Abstract: Background: Despite advances, the treatment of opioid use disorders (OUD) is exceptionally challenging because of its relapsing nature and continuous care to sustain recovery. Timely detection and management of early signs and symptoms (ESS) of relapse are crucial to treating OUD, and heart rate variability (HRV) is suggested to be a potential biomarker for indicators of relapse. The purpose of this mixed-methods pilot study is to understand the ESS of relapse among adults receiving medications for OUD (MOUD) and to explore the correlations between self-report ESS of relapse and HRV as a physiological indicator of relapse. Methods: A prospective mixed-methods observational design was employed. Convenience sampling was used to recruit patients receiving MOUD with buprenorphine in outpatient settings for less than six months. HRV data were collected nightly for eight weeks using a wearable device. Correlations between HRV data and self-reports of ESS of relapse (i.e., craving, self-efficacy, coping, and emotional distress) were examined. Seven virtual focus groups with 23 adults were conducted. Each discussion followed a semi-structured interview guideline. Audio-recorded interviews were transcribed verbatim and analyzed through thematic analysis. A cross-methodological triangulation was used to integrate findings. Results: Of 69 people screened, 55 (79.7%) enrolled in the study, and 23 (41.8%) completed the baseline (week 1) (mean age= 40.1±11.2 years; 60.8% female; and 86.9% white). A significant decrease in self-efficacy and coping, and an increase in depression were found at different study time points (p<0.05). Statistically significant negative correlations were found between HRV, craving, and emotional distress (p<0.05). Qualitative findings identified four emerged themes: 1) relapse as a cognitive-behavioral control process, 2) risk factors for relapse, 3) protective factors for relapse, and 4) challenges. Integration of findings provide insight in understanding of the dynamic process of relapse to substance use. Implications: There is a need for greater clinical attention to the management of self-efficacy, coping, and emotional distress for this population. Understanding the relapsing nature of OUD, triggers, and relapse prevention strategies is critical in providing comprehensive interventions to avoid relapse and cope with high-risk situations. Future research should explore the role of HRV as a potential biomarker to predict other ESS of relapse in a larger longitudinal sample. Monitoring of HRV may be beneficial in developing tailored relapse prevention strategies to minimize the ESS of relapse and promote full recovery.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7018579504
FWCI:
Cites: 127
Cited by:
Related to: 10